Home Analyst Ratings SVB Leerink maintains Accolade ’s rating to Market Perform and price target...

SVB Leerink maintains Accolade [ACCD]’s rating to Market Perform and price target at $53.0

SVB Leerink maintained its Accolade [ACCD] rating to the equivalent of Market Perform but changed the price target to $53.0 from $53, in a research note dated 2021-01-08. That figure represents around a 12.96% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Canaccord Genuity’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in early December. Meanwhile, DA Davidson had launched its coverage on ACCD with “Buy”, in a research note produced for clients September 22, 2020. In addition, SVB Leerink launched coverage on July 27, 2020. The research firm rated ACCD “an Outperform”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

ACCD Price Performance

On Wall Street, Accolade Inc. [NASDAQ:ACCD] finished Thursday’s session up 6.52% at $46.92. The stock went up to $47.50 at the same session while its lowest single day price was $44.60. In the last five days, it saw a rise of about 2.13%, Accolade Inc. shares gained by almost 7.86% since the beginning of the year. However, the share price has dropped to as low as -28.09% below its one year high.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

ACCD Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 45.18 level, and in case of violation of this particular level, it will cause more drop to 43.44 level. On the upper level, 49.24 is still the key resistance. The stock may increase to the subsequent resistance at 48.08. The Relative Strength Index (RSI) pinned on the 14-day chart is 48.33, implying a neutral technical stance while the MACD stands at -3.48, meaning price will decrease in the next trading period. Percent R indicator moved to 58.03%, implying low price movement. Stochastic %K at 27.64% suggest selling the stock.

What is the short interest in Accolade Inc.?

Short interest in the Accolade Inc. stock has plunged, decreasing by -0.13 million shares to total 3.05 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.92 million, data from Yahoo Finance shows. The increase of 4.26% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 8.85% of the overall float for the stock.

Accolade Inc.’s Biggest Shareholders: Who Owns Accolade Inc. [ACCD]?

Filings by Gilder, Gagnon, Howe & Co. LLC showed that the firm now holds a total of 1,311,157 shares or roughly 2.38% of the outstanding ACCD shares. The Brown Advisory LLC’s holdings currently number 660,247 shares at $30978789.24. According to the firm’s last 13F report, T. Rowe Price Associates, Inc. shares in the company at filing stood at 650,902 shares, roughly $33,788,323.

ACCD Earnings Forecast For The Current Quarter

Accolade Inc. [ACCD] is expected to report earnings results for the quarter ending on Feb 2021. Consensus estimates give the company expected revenues of $51.83M and an earnings per share of -$0.13 for Feb 2021. Looking further ahead, the company is expected to report revenue of $43.72M at an EPS of -$0.24 for May 2021. The estimates represent 24.60% and 60.20% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

ACCD Earnings Estimates For The Current Year

For the financial year, Accolade Inc. [NASDAQ:ACCD] is expected to bring in revenue of $160.11M. The returns are nearly $27.6 million higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at -1.86. Estimates put next year’s earnings growth at 60.20%, and at an annual 28.80% over the next 5-year period. As for sales, forecasts are for an increase of 20.80% in the current fiscal year and a further 24.60% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam